Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Works in Genetic & rare · GI & liver · Respiratory

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA is a clinical trial sponsor. It has 2 active clinical trials with 354 planned participants, in Genetic & rare, GI & liver and Respiratory. Since 2021 it has completed 9 trials and stopped 0 early.

Trial track record · since 2021

2Active trials354 planned participants
9Completed7 with results posted
0Stopped early0% of finished trials

Pipeline · 2 active trials

StageTrialStatus

Questions about Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-03.

Approve Suite is not affiliated with Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.